CLAIM CARD
The evidence base for CoQ10 dosing and pharmacokinetic parameters spans diverse clinical contexts and populations. This same trial reported significant reductions in oxidative stress markers, as plasma isofuran concentrations decreased (P = 0.003). Dosing in mechanistic trials has commonly been 100-300 mg per day, as exemplified by the 300 mg/day regimen used in burn patients in Kiani 2024.
Evidence grade: exploratory
Contradiction status: none
Publication: b8dee5f7-0023-4af5-bacc-446de915555a
Provenance: Derivation Web chain
Citation Support
source_1Xu 2024source_2Spiegeleer 2025source_3Shang 2024source_4Alehagen 2020source_5Phan 2020